柿叶黄酮制剂及辛伐他汀对高血压病患者血清炎性因子和脂蛋白(a)水平的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

广东省科技厅科技计划项目(20120613);承担政府特定任务项目 (2012B061700111) 立项课题


The Effects of Persimmon Leaves Flavonoid Preparation and Simvastatin on the Level of Inflammatory Cytokines and Lipoprotein(a) in Serum of the Hypertensives
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探讨高血压病患者常规降压治疗中加用柿叶黄酮制剂对血清部分炎性因子、脂蛋白(a)等因素的影响。方法 严格遵照纳入标准和排除标准,纳入2013年6月至12月于本院确诊的1~2级高血压病患者共90例,随机分为柿叶黄酮组(缬沙坦+脑心清片)、辛伐他汀组(缬沙坦+辛伐他汀)、对照组(缬沙坦),每组30例。用蛋白芯片法检测所有患者入院时及药物治疗6个月后血清中肿瘤坏死因子α、白细胞介素1、白细胞介素6、白细胞介素8、C反应蛋白、内皮素及脂蛋白(a)水平。结果 经药物治疗后,柿叶黄酮组、辛伐他汀组高血压病人血清中炎性因子及脂蛋白(a)水平均明显低于对照组(P<0.01);柿叶黄酮组与辛伐他汀组比较,血清中炎性因子及脂蛋白(a)水平无明显差异(P>0.05)。对照组患者治疗后血压较入院时降低(P<0.05);柿叶黄酮组、辛伐他汀组治疗后与对照组相比血压下降幅度更大(P<0.05),且低密度脂蛋白胆固醇、总胆固醇也有下降(P<0.05)。结论柿叶黄酮制剂或辛伐他汀联合缬沙坦治疗方案均能显著降低高血压病患者血压水平,此外,柿叶黄酮制剂和辛伐他汀还能同时降低高血压病患者血清中多种炎性因子及脂蛋白(a)水平。

    Abstract:

    Aim To evaluate the effects on inflammatory factors,lipoprotein(a) in hypertension patients by adding persimmon leaves flavonoid preparation in conventional antihypertensive therapy. Methods According to the inclusion and exclusion criteria strictly,from Jun to Dec 2013,90 hypertensive patients graded 1~2 were included and randomly divided into three groups: persimmon leaves flavonoid preparation group (valsartan and Naoxinqing tablets),simvastatin group (valsartan and simvastatin),and control group (valsartan),30 patients per group.Serum tumor necrosis factor-α (TNF-α),interleukin-1 (IL-1),IL-6,IL-8,C-reactive protein (CRP),endothelin (ET) and lipoprotein(a) [Lp(a)] were determined by protein chip method before the therapy and 6 months later. Results After treatment,the inflammatory factors and Lp(a) levels of persimmon leaves flavonoid preparation group and simvastatin group were lower than control group (P<0.01),but there were no significant differences on inflammatory factors and Lp(a) levels between the persimmon leaves flavonoid preparation group and the simvastatin group (P>0.05).The blood pressure of patients in control group was significantly reduced after treatment (P<0.05).The blood pressure of patients with the therapy of persimmon leaves flavonoid preparation and simvastatin decreased more than that of control group (P<0.05),and low density lipoprotein cholesterol (LDLC) and triglyceride (TG) were reduced (P<0.05). Conclusions The blood pressure of hypertensives will significantly be depressed after therapy of persimmon leaves flavonoid preparation and simvastatin.In addition,medicine effect of persimmon leaves flavonoid preparation and simvastatin can lead to reduce level of serum inflammatory factors and Lp(a) in hypertension patients.

    参考文献
    相似文献
    引证文献
引用本文

杨志远,马承华,袁明远,杨 溢,刘亚军,刘连红.柿叶黄酮制剂及辛伐他汀对高血压病患者血清炎性因子和脂蛋白(a)水平的影响[J].中国动脉硬化杂志,2014,22(10):1044~1048.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2014-06-26
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: